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Abstract—The binding of activated integrins on the surface
of leukocytes facilitates the adhesion of leukocytes to
vascular endothelium during inﬂammation. Interactions
between selectins and their ligands mediate rolling, and are
believed to play an important role in leukocyte adhesion,
though the minimal recognition motif required for physio-
logic interactions is not known. We have developed a novel
system using poly(ethylene glycol) (PEG) hydrogels modiﬁed
with either integrin-binding peptide sequences or the selectin
ligand sialyl Lewis X (SLe
X) within a parallel plate ﬂow
chamber to examine the dynamics of leukocyte adhesion to
speciﬁc ligands. The adhesive peptide sequences arginine–
glycine–aspartic acid–serine (RGDS) and leucine–aspartic
acid–valine (LDV) as well as sialyl Lewis X were bound to
the surface of photopolymerized PEG diacrylate hydrogels.
Leukocytes perfused over these gels in a parallel plate ﬂow
chamber at physiological shear rates demonstrate both
rolling and ﬁrm adhesion, depending on the identity and
concentration of ligand bound to the hydrogel substrate.
This new system provides a unique polymer-based model for
the study of interactions between leukocytes and endothe-
lium as well as a platform to develop improved scaffolds for
cardiovascular tissue engineering.
Keywords—Poly(ethylene glycol), Hydrogel, Leukocyte
adhesion, Flow chamber.
INTRODUCTION
Leukocyte adhesion to sites of inﬂammation is
crucial to eliminate the cause of irritation and repair
the surrounding tissue. After the initiation of inﬂam-
mation by cytokines such as interleukin-1b (IL-1b),
tumor necrosis factor-a (TNF-a), lipopolysaccharide,
and interleukin-3, (IL-3), leukocyte velocity slows
dramatically due to leukocyte contact with the vascular
wall.
9,27,34Rolling, the initial transient interaction, is
mediated by selectin molecules present on the activated
endothelial cell surface. E-selectin is an inducible sur-
face glycoprotein that is known to bind the carbohy-
drate ligand sialyl Lewis X (SLe
X), which is present on
various leukocytes
10,11,13,35,41,43 and mediates stronger
adhesions and slower rolling than P- or L-selectin.
27
Following this primary contact, ﬁrm adhesion takes
place via activated b2-integrins binding intracellular
adhesion molecule-1 (ICAM-1) expressed on the
endothelium, and through the most important member
of the b1 integrin subfamily, very late antigen-4 (VLA-
4; a4b1). VLA-4 binds vascular cell adhesion molecule-
1 (VCAM-1), and is responsible for lymphocyte
adhesion to vascular endothelium and leukocyte
recruitment to the inﬂamed area.
1,10,11,27 Though well
studied, the exact mechanism of adhesion to the vas-
cular endothelium is not known. There are two sug-
gested mechanisms of integrin activation; one
proposing that activation is a result of chemokine
stimulation of leukocytes
2,43 and another suggesting
that selectin binding leads to integrin activation.
12,42
Several systems have been developed to examine the
dynamics of rolling and ﬁrm adhesion and to elucidate
the exact mechanism of the binding cascade. Leuko-
cytes isolated from human blood have been studied
under static and ﬂow conditions on activated endo-
thelial cell monolayers as well as on cells engineered to
express endothelial cell adhesion molecules.
3,28,37,40
Polystyrene microspheres coated with adhesion ligands
have also been shown to interact with stimulated cell
monolayers
17 and on substrates coated with selectins
and other cell adhesion molecules.
11 Yeast engineered
to display E-selectin has been observed rolling on
substrates coated with SLeX.
2 Recently, poly(ethylene
glycol) (PEG) has been tethered to gold surfaces to
create cell resistant surfaces and spatial gradients of
PEG on gold surfaces have been used to study the
kinetics of static cell adhesion.
32,33 While each of these
systems has revealed new insight into the dynamics of
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1705leukocyte interactions with endothelial cell adhesion
molecules, the ultimate goal must be to establish a
simple, cell-free system that more closely mimics the in
vivo environment.
PEG hydrogels are crosslinked hydrophilic networks
that demonstrate excellent biocompatibility, being
highly resistant to protein adsorption and cell adhesion,
and causing minimal inﬂammatory responses.
20,21,22,36
These highly swollen networks have similar water
content and mechanical properties to soft tissues and
may be engineered to contain cell adhesion peptides,
growth factors, and therapeutics for localized drug
delivery.
5,6,26,29,30,39,44 PEG diacrylate hydrogels may
be covalently modiﬁed with cell adhesive peptide
sequences to encourage cell adhesion, spreading, and
migration and the interactions of cells with these
hydrogels has been extensively studied under static
conditions.
15,16,24,25,29,31,38 A key beneﬁt of such mate-
rials is that the base material, PEG, is intrinsically
resistant to protein adsorption, so the adhesive inter-
actions with cells are limited to the factors that are
speciﬁcally engineered into the hydrogel network. In
this work we propose a novel system to study leukocyte
adhesion under shear using photopolymerized PEG
copolymer hydrogels. After forming thin ﬂat PEG di-
acrylate base hydrogels, we are able to polymerize a
layer of monoacrylate PEG-peptide (or SLe
X) to the
surface, and using a parallel plate ﬂow chamber, we can
observe cell adhesion using video microscopy.
MATERIALS AND METHODS
All chemicals were purchased from Sigma–Aldrich
(St. Louis, MO) unless otherwise stated.
Synthesis of Polyethylene Glycol Diacrylate
Polyethylene glycol diacrylate (PEG-DA) was syn-
thesized by dissolving 12 g dry PEG (MW: 6000;
Fluka, Milwaukee, WI) in 16 ml anhydrous dichlo-
romethane (DCM) with an equimolar amount of tri-
ethylamine and 0.72 g acryloyl chloride (Lancaster
Synthesis, Windham, NH) added dropwise. The mix-
ture was stirred under argon for 24 h, washed with
2MK 2CO3, and separated into aqueous and DCM
phases to remove HCl. The DCM phase was dried
with anhydrous MgSO4 (Fisher Scientiﬁc, Pittsburgh,
PA), and the PEG diacrylate was then precipitated in
diethyl ether, ﬁltered, and dried under vacuum at
room temperature overnight. The resulting polymer
was dissolved in N,N-dimethylformamide-d7 and
characterized via proton NMR (Avance 400 MHz;
Bruker, Billerica, MA) to determine the extent of
acrylation.
Synthesis of PEG Derivatives Containing Cell Adhesion
Molecules
The cell adhesive peptide sequence used in this study
include arginine–glycine–asparagines–serine (RGDS;
American Peptide Company, Inc., Sunnyvale, CA),
and a peptide containing the cell adhesive leucine–
asparagines–valine sequence (glycine–proline–glutamic
acid–isoleucine–leucine–asparagines–valine–serine–
threonine, GPEILDVST), which was synthesized using
standard ﬂuorenylmethoxycarbonyl (Fmoc) chemistry
on an Applied Biosystems 431A peptide synthesizer
(Foster, CA). The high aﬃnity 4-((N¢-2-methylphe-
nyl)ureido)-phenylacetyl-leucine-aspartic acid-valine-
proline (Bio1211; Commonwealth Biotechnologies,
Inc., Richmond, VA)
5,6 was also used as an alternate
LDV-containing compound. The non-adhesive se-
quences used as negative controls were arginine–gly-
cine–glutamic acid–serine (RGES; American Peptide
Company, Inc., Sunnyvale, CA) and glycine–proline–
glutamic acid–isoleucine–leucine–glutamic acid–va-
line–serine–threonine (GPEILEVST), also synthesized
using Fmoc chemistry on a peptide synthesizer.
Peptides were conjugated to PEG monoacrylate by
reaction with acryloyl-PEG-N-hydroxysuccinimide
(PEG-NHS; MW 3400; Nektar Therapeutics, Hunts-
ville, AL) in 50 mM sodium bicarbonate (pH 8.5) at a
1:1 molar ratio for 2 h. The mixture was then dialyzed
(MWCO 1000), lyophilized, and stored at )20 C. Gel
permeation chromatography with UV and evaporative
light scattering detectors (Polymer Laboratories, Am-
herst, MA) was used to determine the coupling efﬁ-
ciency.
The selectin ligand sialyl Lewis X (SLe
X) was con-
jugated to PEG using an avidin–biotin bridge. PEG-
NHS (25 mg) was reacted with a lysine–biotin conju-
gate (biocytin) at a 1:2 molar ratio in 50 mM sodium
bicarbonate (pH 8.5) for 2 h. SLe
X-biotin (500 lg;
Glycotech, Gaithersburg, Maryland) was reacted with
avidin (10–15 units mg
)1) at a ratio of 2 units avidin
per mole of SLe
X-biotin in 50 mM sodium bicarbonate
(pH 8.5) for 2 h. The reaction mixtures were then
combined to allow further conjugation of avidin and
biotin, thereby linking acryloyl–PEG–NHS–lysine–
biotin to avidin–biotin–SLe
X.
Synthesis of Bilayered PEG Copolymer Hydrogels
Hydrogels were formed by ﬁrst dissolving
0.2 g ml
)1 PEG diacrylate in 10 mM HEPES buffered
saline (HBS, pH 7.4); the polymer solution was then
ﬁlter sterilized using a 0.22 lm ﬁlter (Gelman Sciences,
Ann Arbor, MI). The photoinitiator 2,2-dimethoxy-2-
phenyl acetophenone in N-vinylpyrrolidinone (300 mg
ml
)1) was added at 10 llm l
)1 polymer solution. This
TAITE et al. 1706mixture was injected between rectangular glass plates
separated by 0.5 mm spacers and polymerized under
UV light (365 nm, 10 mW cm
)2) for 30 s. The top
plate was removed and the hydrogel surface rinsed
with sterile PBS. A second layer, consisting of
5 lmol ml
)1 of either acryloyl-PEG-peptide or acry-
loyl-PEG-SLe
X in HBS and 10 llm l
)1 2,2-dimethoxy-
2-phenyl acetophenone in N-vinylpyrrolidinone was
then layered on top of the PEG diacrylate base gel, the
upper glass plate replaced, and the second layer pho-
topolymerized by exposure to UV light (365 nm,
10 mW cm
)2) for 1 min.
Cell Maintenance
JURKAT cells (human T-lymphocytes; ATCC,
Manassas, VA) were maintained in RPMI-1640 pre-
pared with 10% fetal bovine serum (FBS; BioWhitaker,
Walkersville, MD), 2 mM L-glutamine, 1 unit ml
)1
penicillin, and 100 mg l
)1 streptomycin (GPS). 300.19/
E cells (mouse pre-B lymphoblast; ATCC, Manassas,
VA) were sustained in RPMI-1640 prepared with 10%
FBS, 1% GPS, and 0.1 mM 2-mercaptoethanol. Cells
were maintained at 37 Ci na5 % CO2 environment.
Cell Adhesion and Rolling on Adhesive PEG Gels
Flow assays were performed using a circular parallel
plate ﬂow chamber (Glycotech, Gaithersburg, MD)
mounted on the stage of a Zeiss Axiovert 135 micro-
scope (Carl Zeiss Inc., Thornwood, NY). The chamber
was placed on top of photopolymerized PEG copoly-
mer hydrogels and vacuum sealed to the surface using
a portable vacuum pump (Fisher Scientiﬁc, Pittsburgh,
PA) as shown in Fig. 1. Cell suspensions were drawn
through the ﬂow ﬁeld (1 cm path width, 0.01 in
thickness) using a programmable syringe pump (BS-
8000 Multi-Phaser  Programmable Syringe Pump,
Braintree Scientiﬁc Inc., Braintree, MA) at varying
ﬂow rates corresponding to a shear stress range of 3.5–
35 dynes cm
)2, which is comparable to in vivo shear
rates. Cellular interactions with the hydrogels were
monitored using a Nikon CoolPix 5000 camera (Nikon
Inc., Melville, NY) and transferred to videotape for
further analysis.
Cation Dependent Binding
JURKAT cells were treated with 2 mM magnesium
(Mg
2+), calcium (Ca
2+), or manganese (Mn
2+)o r
with 10 mM EDTA and then perfused through the
ﬂow chamber and allowed to settle on the gel for
5 min. Controls were exposed to standard formula-
tions of RPMI-1640 containing 0.4 mM Ca
2+ and
0.4 mM Mg
2+. Ten ﬁelds of view were scanned to get
an average number of cells per ﬁeld of view. Flow rates
corresponding to shear stresses of 0.5, 1.0, and 10 dy-
nes cm
)2 were used to wash away unbound cells. The
number of cells remaining for each shear stress was
counted and averaged over several ﬁelds of view.
LDV Speciﬁcity
JURKAT cells treated with 2 mM Mg
2+ were al-
lowed to settle on the LDV gel for 5 min and an
average number of cells per ﬁeld of view was deter-
mined. Speciﬁcity was demonstrated by the addition
7 lgm l
)1 of either a mouse anti-human monoclonal
antibody that blocks VLA-4 binding to VCAM-1
(anti-CD49d, clone BU49; Ancell Corporation, Bay-
port, MN) or an IgG1 isotype control (puriﬁed mouse
myeloma IgG1; Invitrogen Corporation, Carlsbad,
CA) at a shear stress of 0.5 dynes cm
)2. The average
number of cells bound per ﬁeld of view was again
counted to determine the amount of cells remaining
bound to the surface.
Speciﬁcity was also demonstrated by the addition of
a solution of either 10 mM EDTA or 150 lM Bio1211
introduced into the ﬂow chamber under a shear stress
of 0.5 dynes cm
)2. An average number of cells bound
to the gel under ﬂow was determined every minute for
13 min.
Video Analysis
Cells were allowed to settle on each gel for 5 min.
An average of 10 ﬁelds of view was scanned and the
number of cells settled on the peptide gel was counted.
After ﬂow began, ﬁelds of view were scanned again and
the number of cells remaining (bound to the gel) was
counted. After ﬂow was established on the SLeX gels,
video was paused and the number of interacting cells
was counted. The numbers were averaged over 10
ﬁelds of view for each shear stress.
To vacuum pump 
To 
programmable  
syringe pump Flow chamber
Flow Field 
Gasket Layered
hydrogel
Glass plate 
Bottom view of flow chamber
 
FIGURE 1. Schematic of parallel plate ﬂow chamber system.
A small pump is used to create a vacuum, sealing the chamber
on the surface of the gel. Cells are then perfused over the gel
surface using a programmable syringe pump.
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Data were compared with two-tailed, unpaired t-
tests; p-values less than 0.05 were considered to be
signiﬁcant.
RESULTS
Synthesis of PEG Hydrogels
PEG hydrogels were formed under UV light in the
presence of a photoinitiator between two glass plates.
Hydrogels 0.5 mm thick were formed after 30 s of
exposure. The addition of an acryloyl-PEG-peptide
derivative mixed with the photoinitiator to the surface
of the hydrogels resulted in a covalently bound layer of
cell adhesive moiety on the surface (Fig. 1).
Quantiﬁcation of Cell Adhesion and Rolling
Cell rolling on SLeX hydrogels was quantiﬁed over
a range of shear stresses, and 86.8±11.6 cells per ﬁeld
of view rolled on the gel surface at 3.5 dynes cm
)2 with
an average rolling velocity of 141.3 lms
)1 (Fig. 2).
Rolling decreased with increasing shear stress
(7.0 dynes cm
)2: 15.2±3.8 cells, average rolling
velocity 232.7 lms
)1; 14 dynes cm
)2: 8.2±1.9 cells,
average rolling velocity 486.8 lms
)1; 21 dynes cm
)2:
no rolling observed).
Approximately 98.5±18.6% of cells contacting
hydrogel surfaces modiﬁed with Bio1211 adhered to
the gel surface. In comparison, 41.5±13.4% of cells in
contact with the surface of PEG-LDV, an interaction
speciﬁc for the a4b1 integrin expressed on JURKAT
cells, adhered to the hydrogels and 23±8.5% of cells
contacting PEG-RGDS hydrogels adhered to the gel
surface (Fig. 3). No cells adhesion to PEG-DA or
PEG-RGES hydrogels was observed; however the
control LEV peptide-modiﬁed gels had 1.6±1.2% of
cells contacting the surface adhere.
Cation Dependant Binding
Cation sensitivity was assessed by the addition of
cations or EDTA to cell cultures prior to their expo-
sure to PEG-LDV hydrogels. The presence of 10 mM
EDTA had the greatest inhibitory eﬀect on binding,
followed by 2 mM Ca
2+.M g
2+ and Mn
2+ had little
effect on the ability of JURKAT cells to bind LDV,
and a higher number of cells exposed to both calcium
and magnesium were able to bind to the gel surface
than those exposed to calcium alone (Fig. 4).
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FIGURE 2. 300.19/E cells rolling on SLeX modiﬁed gel.
300.19 cells transfected with human E-selectin was perfused
over a SLeX modiﬁed gel. The number of rolling cells were
counted per ﬁeld of view. SLeX ability to support rolling de-
creased as shear stress increased (*p<0.02 as compared to
shear rate of 3.5 dyne cm
)2).
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FIGURE 3. Peptide ability to bind VLA-4. JURKAT cells were
allowed to settle on PEG-DA gels conjugated with different
peptides at similar densities. After 5 min, cells were subjected
to a shear stress of 0.5 dynes cm
)2 to remove unbound cells
and the remaining cells were counted (*p<0.02 compared to
Bio1211).
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FIGURE 4. Cation dependent binding of VLA-4 to LDV pep-
tide. JURKAT cells were incubated with 2 mM cations or
10 mM EDTA prior to settling on the LDV gel; controls were
exposed to standard formulations of RPMI-1640 containing
0.4 mM Ca
2+ and 0.4 mM Mg
2+. The percentage of cells on the
gel was determined based on the total number of cells before
initiating a shear stress of 0.5 dynes cm
)2 (*p<0.05 compared
to Control).
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JURKAT cell binding to PEG-LDV hydrogels was
reversed upon the addition of a monoclonal anti-VLA-
4 (3.4±2.1% bound). Cells exposed to an isotype-
matched control antibody were still able to adhere to
the hydrogel surface (88.8±33.4% bound), demon-
strating speciﬁcity of LDV for the VLA-4 integrin. The
higher aﬃnity of Bio1211 compared to the LDV pep-
tide was also observed by the addition of unbound
Bio1211 after cells were allowed to settle on PEG-LDV
hydrogels (Fig. 5). Bio1211 was able to remove cells
from the gel surface better than EDTA through com-
petitive binding of VLA-4.
The inﬂuence of peptide concentration on cell
adhesion was determined by varying the amounts of
LDV bound to the hydrogel surface (Fig. 6). The
number of cells bound to the gel increased with LDV
concentration, and LDV was better able to support
adhesion at lower shear stresses for all concentrations
when compared to higher rates of shear.
DISCUSSION
The system of hydrophilic hydrogels modiﬁed with
cell adhesion peptides implemented in this study
exhibits the ability to mimic the cell adhesion cascade
that occurs during the onset of inﬂammation in the
vascular system. The capacity to modify hydrogels
with cell adhesion molecules for the study of cellular
interactions with biomaterials for drug delivery and
tissue engineering is well documented.
4,7,15,16,18,24–26,29
–31,38,39,44 This study implements the use of these
materials under physiological ﬂow conditions to
examine the mechanisms of leukocyte rolling and ﬁrm
adhesion.
The formation of thin ﬂat PEG diacrylate hydrogels
for use with a parallel plate ﬂow chamber improves
upon earlier systems that utilize hydrophobic surfaces
with adsorbed cell adhesion molecules. The highly
crosslinked structure of swollen PEG networks have
water content similar to native vessels, and covalent
incorporation of cell adhesive peptides guarantees
control of concentration and allows for patterning of
one or more adhesion sequences on the gel surface.
23
This system is based on a ﬂexible substrate with tun-
able stiffness, the properties of which can be exploited
to examine the responses of different cell types in
microenvironments that mimic native tissues in various
states of development, remodeling, regeneration, and
disease. It has been suggested that the differentiation
of cellular function and response could depend signif-
icantly on matrix elasticity,
8,14,45 and varying the
polymer composition or concentration in the hydrogel
can alter the permeability and mechanical properties,
36
simulating a range of biologically relevant conditions.
In addition, the local mobility of adhesive ligands in
the solvated hydrogel system should be considerably
better than on solid substrates, allowing more variable
orientations which could contribute to a greater frac-
tion of accessible ligands available to receptors on the
cell surface.
Leukocyte cell adhesion to the surfaces of modiﬁed
PEG-DA hydrogels was highly speciﬁc, reversible, and
sensitive to ligand site density and aﬃnity, demon-
strating the eﬃcacy of the system to mimic the events
leading to the ﬁrm adhesion of immune cells on
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FIGURE 5. LDV Speciﬁcity for VLA-4. 10 mM EDTA or 1.5 uM
Bio1211 was introduced into the ﬂow chamber at a wall shear
stress of 0.5 dynes cm
)2 after JURKAT cells were allowed to
settle on the LDV gel for 5 min. Bio1211, which has a higher
afﬁnity for VLA-4 was able to compete the cells off the LDV
modiﬁed gel surface. EDTA was not as effective as Bio1211 as
cells detached more slowly and not completely. The dashed
line represents the uninhibited controls, in which 40±15.2%
of the cells initially exposed to the hydrogel remained bound
through the duration of the experiment. Each data point rep-
resents the average percent of bound cells per 10 ﬁelds of
view and error bars represent the standard deviation of the
percent of bound cells within those 10 ﬁelds of view.
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FIGURE 6. Dilution effect of LDV. The number of JURKAT
cells bound to the gel decreased as the LDV peptide con-
centration was lowered. LDV was better able to support
adhesion at lower shear stresses for all concentrations
(*p<0.05 comparing shear rates at each concentration).
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cells on the surfaces of PEG-SLe
X hydrogels conﬁrms
the integration of SLe
X into the system through the use
of an avidin–biotin linkage, which did not disrupt the
active binding site of the carbohydrate. Incorporation
of the RGD and LDV peptides encouraged ﬁrm cell
adhesion to the materials surface under shear in a
concentration dependant manner, and cells remained
adherent throughout the duration of the ﬂow experi-
ment. These results illustrate that this method of
studying leukocyte adhesion succeeds in mimicking the
interactions seen on the in vivo vascular wall under
shear. With further optimization, such as incorpora-
tion of signaling molecules, this system using of PEG
gels can improve insight into the mechanisms of rolling
and ﬁrm cell adhesion at sites of active vascular disease.
CONCLUSIONS
The covalent modiﬁcation of PEG hydrogel surfaces
with cell adhesive peptides was accomplished in con-
tinuous layers of adhesive regions. These materials
encouraged vascular cell adhesion through both tran-
sient interactions with selectin molecules and ﬁrm
binding via integrins. The system presented here to
expose adhesive hydrogels to cells under ﬂow condi-
tions represents a method to study cell–material
interactions in environments that closely mimic in vivo
environments.
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